| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 70.6% | 77/109 |
| Female | 29.4% | 32/109 |
| Indifferent | 0% | 0/109 |
| Unknown | 0% | 0/109 |
| General | ||
| Birth Length | 0% | 0/92 |
| 8.5% | 8/94 | |
| 9.8% | 9/92 | |
| 46.2% | 43/93 | |
| 29% | 27/93 | |
| 50.5% | 52/103 | |
| 44.2% | 42/95 | |
| 54.7% | 52/95 | |
| 64.6% | 62/96 | |
| 79.7% | 55/69 | |
| Neurology | ||
| 43.1% | 47/109 | |
| 80.7% | 88/109 | |
| 13.8% | 15/109 | |
| Facial abnormalities | ||
| 18.3% | 20/109 | |
| 34.9% | 38/109 | |
| 18.3% | 20/109 | |
| 11.9% | 13/109 | |
| Visual and hearing impairments | ||
| 4.6% | 5/109 | |
| 6.4% | 7/109 | |
| Heart | ||
| 5.5% | 6/109 | |
| Pulmonary | ||
| Abnormality of the lungs | 0% | 0/3 |
| Gastrointestinal | ||
| 33% | 36/109 | |
| Urogenital | ||
| 8.3% | 9/109 | |
| Skeleton | ||
| 33% | 36/109 | |
| Skin / Hair / Nails | ||
| 11.9% | 13/109 | |
| Endocrine / Immunological / Metabolic | ||
| 5.5% | 6/109 | |
| 5.5% | 6/109 | |
| 5.5% | 6/109 | |
| Neoplasia | ||
| 3.7% | 4/109 | |
| Inheritance | ||
| 86% | 74/86 | |
